Question 1

What are the potential benefits of adding brivanib to my TACE treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC clinical trial (NCT00908752). Contact the study team or your healthcare provider for specific answers.

Question 2

How does brivanib compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC clinical trial (NCT00908752). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of while taking brivanib?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC clinical trial (NCT00908752). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC clinical trial (NCT00908752). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC clinical trial (NCT00908752). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific tests or monitoring I will need while on this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC clinical trial (NCT00908752). Contact the study team or your healthcare provider for specific answers.

What this study is about